Display options
Share it on

Clin Neurophysiol. 2021 Dec;132(12):3010-3018. doi: 10.1016/j.clinph.2021.08.021. Epub 2021 Oct 08.

Ketamine induces EEG oscillations that may aid anesthetic state but not dissociation monitoring.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

Shubham Chamadia, Jacob Gitlin, Jennifer Mekonnen, Breanna R Ethridge, Reine Ibala, Katia M Colon, Jason Qu, Oluwaseun Akeju

Affiliations

  1. Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
  2. Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA. Electronic address: [email protected].

PMID: 34715426 PMCID: PMC8629941 DOI: 10.1016/j.clinph.2021.08.021

Abstract

OBJECTIVE: Ketamine is an anesthetic drug associated with dissociation. Decreased electroencephalogram alpha (8-13 Hz) and low-beta (13-20 Hz) oscillation power have been associated with ketamine-induced dissociation. We aimed to characterize surface electroencephalogram signatures that may serve as biomarkers for dissociation.

METHODS: We analyzed data from a single-site, open-label, high-density surface electroencephalogram study of ketamine anesthesia (2 mg/kg, n = 15). We assessed dissociation longitudinally using the Clinician Administered Dissociation States Scale (CADSS) and administered midazolam to attenuate dissociation and enable causal inference. We analyzed electroencephalogram power and global coherence with multitaper spectral methods. Mixed effects models were used to assess whether power and global coherence signatures of ketamine could be developed into dissociation-specific biomarkers.

RESULTS: Compared to baseline, ketamine unresponsiveness was associated with increased frontal power between 0.5 to 9.3 Hz, 12.2 to 16.6 Hz, and 24.4 to 50 Hz. As subjects transitioned into a responsive but dissociated state (mean CADSS ± SD, 22.1 ± 17), there was a decrease in power between 0.5 to 10.3 Hz and 11.7 to 50 Hz. Midazolam reduced dissociation scores (14.3 ± 11.6), decreased power between 4.4 to 11.7 Hz and increased power between 14.2 to 50 Hz. Our mixed-effects model demonstrated a quadratic relationship between time and CADSS scores. When models (frontal power, occipital power, global coherence) were reanalyzed with midazolam and electroencephalogram features as covariates, only midazolam was retained.

CONCLUSIONS: Ketamine is associated with structured electroencephalogram power and global coherence signatures that may enable principled anesthetic state but not dissociation monitoring.

SIGNIFICANCE: A neurophysiological biomarker for dissociation may lead to a better understanding of neuropsychiatric disorders.

Copyright © 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Keywords: CADSS; Dissociation; EEG; Ketamine; Spectral

Conflict of interest statement

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: OA has received speaker's honor

References

  1. J Nerv Ment Dis. 1997 Dec;185(12):755-60 - PubMed
  2. J Anxiety Disord. 2004;18(4):435-58 - PubMed
  3. CNS Neurosci Ther. 2013 Jun;19(6):396-402 - PubMed
  4. Anesthesiology. 2020 Nov 1;133(5):970-972 - PubMed
  5. Elife. 2021 May 10;10: - PubMed
  6. Front Syst Neurosci. 2014 Jul 01;8:114 - PubMed
  7. Curr Opin Neurobiol. 2017 Jun;44:178-185 - PubMed
  8. Ann Emerg Med. 2011 Feb;57(2):109-114.e2 - PubMed
  9. Clin Neurophysiol. 2016 Jun;127(6):2472-81 - PubMed
  10. Pharmacol Biochem Behav. 2021 Feb;201:173092 - PubMed
  11. Clin Neurophysiol. 2016 Jun;127(6):2414-22 - PubMed
  12. Nature. 2020 Oct;586(7827):31-32 - PubMed
  13. J Trauma Stress. 1998 Jan;11(1):125-36 - PubMed
  14. Neuroimage. 2021 Aug 15;237:118171 - PubMed
  15. Anesthesiology. 2020 Nov 1;133(5):1021-1028 - PubMed
  16. Can J Anaesth. 2000 Sep;47(9):866-74 - PubMed
  17. Nature. 2020 Oct;586(7827):87-94 - PubMed
  18. Br J Anaesth. 2019 Aug;123(2):206-218 - PubMed
  19. Am J Psychiatry. 2016 Aug 1;173(8):816-26 - PubMed
  20. Mol Psychiatry. 2020 Jul;25(7):1592-1603 - PubMed
  21. J Affect Disord. 2018 Feb;227:11-16 - PubMed
  22. Nat Commun. 2020 Dec 22;11(1):6431 - PubMed
  23. Anesthesiology. 2014 Nov;121(5):990-8 - PubMed
  24. Anesthesiology. 2010 Sep;113(3):678-84 - PubMed
  25. Front Hum Neurosci. 2016 Nov 29;10:612 - PubMed
  26. Clin Psychol Rev. 2014 Aug;34(6):482-95 - PubMed
  27. Front Pharmacol. 2016 Sep 27;7:348 - PubMed
  28. Eur J Pharmacol. 2019 Oct 5;860:172547 - PubMed
  29. Br J Anaesth. 2018 Jul;121(1):249-259 - PubMed
  30. Front Syst Neurosci. 2017 May 30;11:38 - PubMed
  31. Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):330-57 - PubMed
  32. Anesthesiology. 2015 Oct;123(4):937-60 - PubMed
  33. Annu Rev Neurosci. 2011;34:601-28 - PubMed
  34. Commun Biol. 2019 Nov 15;2:415 - PubMed
  35. Br J Anaesth. 2007 Sep;99(3):389-95 - PubMed

Publication Types

Grant support